WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004032870) METHODS FOR TREATING POST-SURGICAL PAIN BY ADMISNISTERING A NERVE GROWTH FACTOR ANTAGONIST AND COMPOSITIONS CONTAINING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/032870    International Application No.:    PCT/US2003/032089
Publication Date: 22.04.2004 International Filing Date: 08.10.2003
Chapter 2 Demand Filed:    10.05.2004    
IPC:
C07K 16/28 (2006.01)
Applicants: RINAT NEUROSCIENCE CORP. [US/US]; 3155 Porter Drive, Palo Alto, CA 94304 (US) (For All Designated States Except US).
SHELTON,David, L. [US/US]; (US) (For US Only).
VERGARA, German, J. [US/US]; (US) (For US Only)
Inventors: SHELTON,David, L.; (US).
VERGARA, German, J.; (US)
Agent: COBURN, Cara, M.; Morrison & Foerster LLP, 755 Page Mill Road, Palo Alto, CA 94304 (US)
Priority Data:
60/417,237 08.10.2002 US
Title (EN) METHODS FOR TREATING POST-SURGICAL PAIN BY ADMISNISTERING A NERVE GROWTH FACTOR ANTAGONIST AND COMPOSITIONS CONTAINING THE SAME
(FR) PROCEDES DE TRAITEMENT D'UNE DOULEUR POST-CHIRURGICALE PAR ADMINISTRATION D'UN ANTAGONISTE DU FACTEUR DE CROISSANCE NEURONAL, ET COMPOSITIONS RENFERMANT CELUI-CI
Abstract: front page image
(EN)The invention features methods and compositions for preventing or treating pain resulting from surgery or an incision by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
(FR)L'invention concerne des procédés et des compositions destinés à empêcher ou à traiter la douleur résultant d'une opération chirurgicale ou d'une incision, par administration d'un antagoniste du facteur de croissance neuronal (NGF). L'antagoniste NGF peut être un anticorps anti-NGF (tel que l'anti-hNGF) capable de se lier à hNGF.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)